Search Drug Information, Interactions, Images, Dosage & Side Effects

Dietary modification ups glaucoma risk in women 04 Jun 2023
Dietary modification (DM) among individuals in the lowest quartile for percentage calories from total fat at baseline is associated with a higher risk of incident primary open-angle glaucoma (POAG) among women, irrespective of age or race, suggests a recent study.

Sexual dysfunction in young adult cancer survivors tied to fatigue, worse sleep, severe pain

04 Jun 2023

Atopic dermatitis poses heightened risk of venous thromboembolism

03 Jun 2023

Diabetes limits weight loss after bariatric surgery

03 Jun 2023

What is the best predictor of glucose metabolism deterioration after bariatric surgery?

03 Jun 2023

Multimodal neuromuscular treatment eases pain, improves functionality in vulvodynia

03 Jun 2023

Quitting beneficial for mental health outcomes in smokers

03 Jun 2023

Adverse pregnancy outcomes spell increased stroke risk

02 Jun 2023

Eating well boosts brain health, promotes well-being for older Singaporeans

02 Jun 2023

Opioid overdose more likely in patients who discontinue or don’t start treatment

02 Jun 2023

Premeal almonds reduce insulin levels, improve glycaemic control in prediabetes

02 Jun 2023

CAR T-cell therapy enables chemo-free treatment of R/R follicular lymphoma 30 May 2023;
While most patients with follicular lymphoma (FL) can expect to live for another 20 years after diagnosis, a significant minority relapse within 2 years and have considerably worse prognosis. At a symposium organized by the Hong Kong Society of Haematology, Professor Catherine Thieblemont of the Haemato-Oncology Department, Hôpital Saint-Louis, Paris, France, a key investigator on the ELARA trial, reviewed chemotherapy-free options for relapsed/refractory (R/R) FL and shared her experience of using a chimeric antigen receptor (CAR) T-cell therapy, tisagenlecleucel, in a heavily pretreated patient.

First-line androgen receptor inhibitor plus low-dose prednisolone in a patient with mCRPC and comorbidities

Prof. Chi-Fai Ng, 30 May 2023

Real-world PACIFIC-R study reaffirms survival benefits of consolidation durvalumab in unresectable NSCLC

Prof. Nicolas Girard, 30 May 2023

Chemotherapy-induced nausea and vomiting: Guideline update and role of netupitant/palonosetron

Prof. Roger Ngan, Dr. Cheng-Vai Hui, 30 May 2023

Kerendia

Contents : Finerenone

Indications/Uses : Delays progressive decline of kidney function in adults w/ CKD associated w/ type 2 diabetes (w/ albuminuria), in addition to standard of care.